GlassScriptPhysician profile
Jella A An
NPI 1033567763
$166,279.23
in general payments reported to CMS, 2019-2025
19 companies · $70K in 2025
The $70K reported for 2025 was more than what 99% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,934 · 2020: $15K · 2021: $30K · 2022: $30K · 2023: $12K · 2024: $2,689 · 2025: $70K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $38K · Consulting Fee: $31K · Food and Beverage: $8,219 · Travel and Lodging: $7,601 · Honoraria: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $37,562.50 |
| Consulting Fee | $31,125.00 |
| Food and Beverage | $8,218.51 |
| Travel and Lodging | $7,601.35 |
| Honoraria | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $61,963.12 | 2019-2025 | Hydrus Microstent, Voyager Dslt, Simbrinza |
| Sight Sciences, INC. | $25,317.55 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Iridex Corporation | $23,390.79 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $18,276.96 | 2019-2021 | |
| New World Medical,INC. | $14,514.44 | 2019-2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Streamline |
| Abbvie INC. | $9,084.30 | 2022-2025 | Xen Glaucoma Treatment System, Durysta, Lumigan |
| Ivantis, INC | $4,532.07 | 2019-2021 | |
| Allergan, INC. | $3,574.16 | 2019-2022 | |
| Carl Zeiss Meditec USA, INC. | $1,650.54 | 2023 | Artevo 800, Veracity Surgical, Visumax |
| Bausch & Lomb Americas INC. | $1,519.81 | 2024-2025 | Xiidra, Miebo, Vyzulta |
| Alcon Research LLC | $1,000.00 | 2025 | Viscoat |
| Glaukos Corporation | $580.14 | 2024-2025 | Idosetr, Istent Infinite, Idose |
| Johnson & Johnson Surgical Vision, INC. | $250.51 | 2021-2025 | Tecnis Iol, Catalys System, Tecnis Simplicity |
| Dompe US, INC. | $171.12 | 2022-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $153.62 | 2019-2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recordati_rare_diseases_inc. | $123.98 | 2025 | Cystadrops |
| Carl Zeiss Meditec, INC. | $92.19 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $60.41 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $23.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jella An listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.